National Comprehensive Cancer Network

About NCCN

NCCN Publishes New Patient Education Resources for Hodgkin Lymphoma; Updates Lung Cancer Screening Resources

Because of clinical advances over the past three decades, Hodgkin Lymphoma, although rare, is curable in at least 80 percent of patients with five-year survival rates that are unmatched in any other cancer.i

To further educate people with Hodgkin Lymphoma and their caregivers about the most effective treatment options for their disease, the National Comprehensive Cancer Network® (NCCN®) has published the NCCN Guidelines for Patients® and NCCN Quick Guide™ series for Hodgkin Lymphoma, the newest addition to NCCN’s library of patient education resources. Made available through support of the NCCN Foundation®, the NCCN Guidelines for Patients and NCCN Quick Guide™ series for Hodgkin Lymphoma are available to download free of charge on; for information about print copies, visit

“Through providing free resources for people with Hodgkin Lymphoma, NCCN Foundation strives to empower patients to work alongside their care team to make informed decisions about their treatment,” said Marcie R. Reeder, MPH, Executive Director, NCCN Foundation.

The NCCN Guidelines for Patients and NCCN Quick Guide™ series for Hodgkin Lymphoma provides users with the most pertinent information: diagnosis, treatment planning, and treatment options for Classical Hodgkin Lymphoma and Nodular Lymphocyte-Predominant Hodgkin Lymphoma.

The NCCN Guidelines for Patients, translations of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) are designed to provide people with cancer and their caregivers with state-of-the-art treatment information in east-to-understand language. The NCCN Guidelines® are developed by multidisciplinary panels of experts from NCCN Member Institutions and feature algorithms that address appropriate management options from initial work-up through the course of the disease.

NCCN Guidelines for Patients and NCCN Quick Guide™ series, abbreviated references outlining key points of the NCCN Guidelines for Patients, are written according to plain language principles to improve health literacy, and the design and format feature patient-friendly elements, such as medical illustrations of anatomy, tests, and treatments. NCCN Guidelines for Patients®: Hodgkin Lymphoma also features an expansive glossary of terms and acronyms. The NCCN Guidelines for Patients and the NCCN Quick Guide™ series do not replace the expertise and clinical judgment of the physician.

NCCN currently offers NCCN Guidelines for Patients for the following: Breast, Colon, Esophageal, Kidney, Non-Small Cell Lung, Ovarian, Pancreatic, and Prostate Cancers; Acute Lymphoblastic Leukemia; Caring for Adolescents and Young Adults (AYA); Chronic Myelogenous Leukemia; Hodgkin Lymphoma; Lung Cancer Screening, Malignant Pleural Mesothelioma; Melanoma; Multiple Myeloma; and Soft Tissue Sarcoma.

Through philanthropy, the NCCN Foundation empowers people through knowledge and advances the mission of NCCN to improve the quality, effectiveness, and efficiency of cancer care, so that patients can live better lives.

To download or order the NCCN Guidelines for Patients and NCCN Quick Guide™ series for Hodgkin Lymphoma, visit

Updates to NCCN Guidelines for Patients®: Lung Cancer Screening

Effective screening of lung cancer has the potential to detect cancer early and decrease mortality.

The updated NCCN Guidelines for Patients®: Lung Cancer Screening aims to help people make informed decisions about lung cancer screening. It explains why screening is important, who is at risk for lung cancer, and for whom screening is recommended.

A shared decision-making process between doctor and patient on whether to start screening is encouraged especially in light of the benefits and risks of lung cancer screening. 

To access the NCCN Guidelines for Patients®: Lung Cancer Screening, visit



i "NCCN Guidelines for Hodgkin Lymphoma, V 2.2015." National Comprehensive Cancer Network, 20 Apr. 2015. Web. 8 Dec. 2015.